Depression and anxiety in elderly patients with chronic obstructive pulmonary disease
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity, disability and mortality in old age [1]. It has been predicted that COPD will be the world’s fifth-ranking cause of disability by 2020 [2]. Co-morbid psychological impairments (depression and anxiety) are common in COPD and are often associated with increased disability and morbidity. They also impair quality of life in COPD and are often not fully explored in the clinical management of COPD patients. In the UK, the National Institute of Clinical Excellence COPD Guidelines [1] estimates the prevalence of depression in COPD to be 40% (36–44%) and suggests that anxiety symptoms may have a prevalence of 36% (31–41%) [3]. With such a high prevalence, why is depression so often undetected and untreated? First, recognition of co‐morbid depression is difficult, because some of the physical symptoms of COPD may mimic the core symptoms of depression, for example, poor sleeping pattern, anorexia and loss of enjoyment due to breathlessness. Second, screening tools for depression and anxiety symptoms are not routinely employed by health care professionals caring for COPD patients. Third, patients often deny that they are suffering from anxiety and depression, perhaps because of perceptions of the stigma attached to these problems [4]. Unrecognised and untreated depression has major implications in compliance with medical treatment and may increase the frequency of consultation with health services, for example, in primary care [5]. In COPD, it increases the likelihood of hospital admission in those most severely disabled [4]. Anxiety is common in patients with COPD. It is often associated with clinical depression, and a study from our centre identified that 37% of depressed COPD patients had clinical anxiety compared with 5% of non-depressed COPD patients [4]. COPD is among a number of medical disorders associated with a high rate of depression. The wide range of conditions suggest that the aetiology is multifactorial. Suggested mechanisms include cerebrovascular and microangiopathy (heart disease, diabetes), localised disruption to fronto-striatal brain circuits (stroke), social adversity (diabetes) and neurodegenerative brain disease (Alzheimer’s disease, idiopathic Parkinson’s disease), pain (arthritis, cancer) and oncological therapy (cancer) [6]. Furthermore, there is robust evidence that depression worsens the outcome and mortality of many of these conditions [6], and this has been demonstrated for COPD too [7]. There is little data regarding aetiological mechanisms leading to depression in COPD. However, disability and handicap are powerful predictors of depression and are likely to be the major determinants in COPD [8]. Whether biological mechanisms play a significant role has not been clarified. Routine screening for depression in patients with COPD would be justified if (i) there was an adequately tested and validated tool available that was simple and user-friendly and (ii) treatment of psychological difficulties in this situation was effective and acceptable to the patient population. The evidence base at present suggests that the former condition is satisfied but the latter is probably not. We have recently validated the Brief Assessment Schedule Depression Cards [BASDEC] [4] to diagnose depression in this patient group. The BASDEC performed with a sensitivity of 100% and a specificity of 90% when compared against the Geriatric Mental State Schedule which is a research benchmark for the diagnosis of clinical depression. The BASDEC is simple to use, takes about 5 min to administer at the bedside and can be done by any health care professional following brief training. Before employing a screening tool, it is important to explain the purpose and relevance of assessment to patients. In our experience, many patients with elevated depression scores tend to deny that they are suffering from depression and refuse to accept either treatment or referral to a mental health care specialist [9]. After diagnosing co-morbid anxiety or depression, it is also important to explain why seeking treatment for depression is potentially worthwhile. Health care professionals should be aware of patients’ misgivings and be prepared to help the patient come to a decision about treatment. Having a choice of interventions may help this process. A recent study of depressed patients in a primary care setting that investigated patients’ preferred choice of treatment (antidepressant medication versus counselling) reported a better response and compliance with treatment in patients who had a choice of treatment compared with a non-choice comparison group [10]. It is also worth exploring how family and friends may be involved in supporting the patient and to encourage social interaction. Educating the spouse, family members and friends about depression may help them to understand the consequences of the disease and to develop coping strategies and in turn may reduc
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
Emery, C. F., Schein, R. L., Hauck, E. R., & MacIntyre, N. R. (1998) · Health Psychology · doi:10.1037/0278-6133.17.3.232 · Cited by 353
KUNIK, M. E., BRAUN, U., STANLEY, M. A., WRISTERS, K., MOLINARI, V., STOEBNER, D., & ORENGO, C. A. (2001) · Psychological Medicine · doi:10.1017/s0033291701003890 · Cited by 204 · cited 1×
“Kunik and co-workers [13] found a significant improvement in anxiety and depression scores in a group of depressed patients given a single 2-h session of cognitive behavioural therapy (CBT) compared with education alone.”
BackgroundThe influence of patient preference on depression treatment in primary care
Lin, P., Campbell, D. G., Chaney, E. F., Liu, C.-F., Heagerty, P., Felker, B. L., & Hedrick, S. C. (2005) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm3002_9 · Cited by 192 · cited 1×
“A recent study of depressed patients in a primary care setting that investigated patients’ preferred choice of treatment (antidepressant medication versus counselling) reported a better response and compliance with treatment in patients who had a choice of treatment compared with a non-choice comparison group [10].”
BackgroundYohannes, A. M., Baldwin, R. C., & Connolly, M. J. (2005) · Age and Ageing · doi:10.1093/ageing/afi163 · Cited by 131
Self-citationYohannes, A. M., Connolly, M. J., & Baldwin, R. C. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.461 · Cited by 124
Self-citation
Research works printed but not linked: 8
- Murray CJ , Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet1997; 349: 1498–504. · DOI · Paper page
- Yohannes AM , Baldwin RC, Connolly MJ. Mood disorders in elderly patients with chronic obstructive pulmonary disease. Rev Clin Gerontol2000; 10: 193–202. · DOI · Paper page
- Yohannes AM , Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry2000; 15: 1090–6. · doi:10.1002/1099-1166(200012)15:12<1090::aid-gps249>3.0.co;2-l
- Evans DL , Charney DS, Lewis L et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry,2005; 58: 175–89. · DOI · Paper page
- Prince MJ , Harwood RH, Thomas A, Mann AH. A prospective population-based cohort study of the effects of disablement and social milieu on the onset and maintenance of late-life depression. The Gospel Oak Project VII. Psychol Med1998; 28: 337–50. · DOI · Paper page
- Nasser EH , Overholser JC. Recovery from major depression: the role of support from family, friends, and spiritual beliefs. Acta Psychiatr Scand2005; 111: 125–32. · DOI · Paper page
- Lacasse Y , Beaudoin L, Rousseau L, Maltais F. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis2004; 61: 140–7. · DOI · Paper page
- Withers NJ , Rudkin ST, White RJ. Anxiety and depression in severe chronic obstructive pulmonary disease: the effects of pulmonary rehabilitation. J Cardiopulm Rehabil1999; 19: 362–5. · DOI · Paper page
Cited by
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
Exacerbations of chronic obstructive pulmonary disease
Celli, B. R., & Barnes, P. J. (2007) · European Respiratory Journal · doi:10.1183/09031936.00109906 · Cited by 462
Anxiety and depression in end-stage COPD
Hill, K., Geist, R., Goldstein, R. S., & Lacasse, Y. (2008) · European Respiratory Journal · doi:10.1183/09031936.00125707 · Cited by 269
Coventry, P. A., & Hind, D. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2007.08.002 · Cited by 197
“People with COPD experience increased levels of psychosocial morbidity comparable with those associated with other chronic physical disease groups [6]: a metaanalysis of 13 studies (n=900) found that the prevalence of depression was 40% (95% CI: 36–44%), and for anxiety was 36% (95% CI: 31–46%) [7], significantly high…”
BackgroundA randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD
Hynninen, M. J., Bjerke, N., Pallesen, S., Bakke, P. S., & Nordhus, I. H. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.02.020 · Cited by 152
Metadata
- Authors
- Yohannes, A. M., Baldwin, R. C., & Connolly, M. J.
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-04-25
- Volume
- 35
- Issue
- 5
- Pages
- 457-459
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- OpenAlex
- W2106636625
- Cited by
- 93
- References
- 6
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.